Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cMet antibody drug conjugates and methods for their use

Anti-cMet antibody drug conjugates and methods for their use

US Patent 10603389 · Granted Mar 31, 2020

Estimated economic value: $762,291,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stabilized liquid anti-RSV antibody formulations2021
Stabilized liquid anti-RSV antibody formulations2020
Anti-cMet antibody drug conjugates and methods for their use2019
Anti-cMet antibody drug conjugates and methods for their use2019
Anti-cMet antibody drug conjugates and methods for their use2019
Anti-CS1 antibodies and antibody drug conjugates2019
Prolactin receptor binding proteins and uses thereof2019
Anti-PRLR antibody-drug conjugates (ADC) and uses thereof2018
Anti-EGFR antibodies and antibody drug conjugates2018
Anti-CS1 antibodies and antibody drug conjugates2018
Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof2018
Stabilized liquid anti-RSV antibody formulations2018